Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 151

Working Capital lands funding from Zalando

Zalando and Children’s Investment Fund Foundation have added $2.5m to Working Capital's supply chain-focused fund, which now stands at $25.2m.

Sep 23, 2018

Medtronic marks Mazor for acquisition

Technion’s robotic surgery business Mazor Robotics has been snapped up by medical device developer Medtronic, which had already invested $72m in the company.

Sep 21, 2018

Amicus captures Celenex

Nationwide Children’s Hospital spinout Celenex could fetch as much as $452m upon completion of milestones after progressing rare disease therapies conceived at the hospital’s collaborative program with Ohio State University.

Sep 20, 2018

Infosys sucks up Fluido in $76m acquisition

Salesforce Ventures is set to exit CRM services provider Fluido three years after backing a $3.5m round, in an acquisition by Infosys.

Sep 20, 2018

Boehringer Ingelheim greets ViraTherapeutics in $245m purchase

Cancer drug developer ViraTherapeutics has been acquired by Boehringer Ingelheim, three years after the corporate led its series A round.

Sep 14, 2018

WeWork gets a new Teem in $100m deal

GE Ventures and NGP Capital have exited workplace software provider Teem in a $100m acquisition by WeWork.

Sep 14, 2018

NetGear draws up Meural acquisition

Electronic art frame producer Meural has been acquired by NetGear less than a year after the corporate took part in its series A round.

Sep 13, 2018

Intel catches NetSpeed in acquisition deal

Network-on-chip technology developer NetSpeed has been acquired by Intel, an investor in the company since 2014, for an undisclosed amount.

Sep 13, 2018

Chain tethers to Lightyear to go Interstellar

Chain, a blockchain technology provider backed by Visa, Orange, Fiserv, Nasdaq, Citi and Capital One, has merged with Lightyear to form a new company dubbed Interstellar.

Sep 12, 2018

Augmenix gels with Boston Scientific for $600m

Boston Scientific will pay $500m upfront and up to $100m in milestone payments to acquire Augmenix, providing exits to Varian Medical Systems and Ascension Health.

Sep 10, 2018
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here